tiprankstipranks
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Financial Statements

50 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently ―. The company's EPS TTM is $-0.161; its P/E ratio is -3.52; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 2.55M$ 2.57M$ 2.38M$ 2.84M$ 2.58M
Gross Profit$ 354.33K$ 339.71K$ 368.90K$ 382.67K$ 299.50K
EBIT$ -2.53M$ -275.24K$ -50.63K$ -96.69K$ -65.22K
EBITDA$ -2.50M$ -250.63K$ -25.76K$ -99.01K$ -39.38K
Net Income Common Stockholders$ -2.61M$ -259.25K$ -69.07K$ -29.39K$ -77.40K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.70M$ 297.08K$ 1.97M$ 2.12M$ 1.46M
Total Assets$ 11.47M$ 7.90M$ 8.19M$ 8.74M$ 7.80M
Total Debt$ 138.76K$ 45.76K$ 52.41K$ 56.77K$ 25.90K
Net Debt$ -4.57M$ -251.33K$ -1.92M$ -2.06M$ -1.44M
Total Liabilities$ 1.78M$ 1.94M$ 1.63M$ 2.08M$ 1.37M
Stockholders Equity$ 9.69M$ 5.96M$ 6.56M$ 6.67M$ 6.42M
Cash Flow-
Free Cash Flow$ -1.03M$ -36.38K$ -118.40K$ 457.44K$ 303.50K
Operating Cash Flow$ -899.35K$ -22.04K$ -118.30K$ 474.47K$ 307.15K
Investing Cash Flow$ -360.71K$ -3.06K$ -5.06K$ -49.90K$ 18.36K
Financing Cash Flow$ 5.75M$ -4.21K--$ 0.00
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

BioNexus Gene Lab Corp Debt to Assets

BioNexus Gene Lab Corp Cash Flow

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis